SCHEMBL3414735

SCHEMBL3414735

CCN(CC)C(=O)c1ccc(-c2cccnc2)o1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 11/20 0.51
CYP2C19 P33261 7/20 0.51
CYP3A4 P08684 7/20 0.51
CYP2D6 P10635 6/20 0.51
CYP2C9 P11712 6/20 0.51
CYP2E1 P05181 5/20 0.51
CYP2B6 P20813 5/20 0.51
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 2/20 0.44
NPC1 O15118 1/20 0.44
USP2 O75604 1/20 0.44
MAPT P10636 1/20 0.44
MAPK1 P28482 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HSD17B10 Q99714 1/20 0.44
HSD17B1 P14061 2/20 0.44
LMNA P02545 1/20 0.44
FAAH O00519 1/20 0.43
CES1 P23141 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17424211 0.89 CYP2A6 (0.45) CYP2A6CYP2C19CYP3A4CYP2D6CYP2C9
SCHEMBL3416947 0.89 CYP2A6 (0.46) CYP2A6CYP2C19CYP3A4CYP2D6CYP2C9
SCHEMBL17424348 0.89 CYP2A6 (0.45) CYP2A6CYP2C19CYP3A4CYP2D6CYP2C9
SCHEMBL17424205 0.88 CYP2A6 (0.52) CYP2A6CYP2C19CYP3A4CYP2D6CYP2C9
SCHEMBL3419995 0.85 CYP2A6 (0.54) CYP2A6CYP2C19CYP3A4CYP2D6CYP2C9
SCHEMBL27605095 0.79 CYP2A6 (0.57) CYP2A6CYP2C19CYP3A4CYP2D6CYP2C9
SCHEMBL3414768 0.79 CYP2A6 (0.48) CYP2A6CYP2C19CYP3A4CYP2D6CYP2C9
SCHEMBL17424206 0.79 CYP2A6 (0.48) CYP2A6CYP2C19CYP3A4CYP2D6CYP2C9
SCHEMBL23091230 0.78 ALDH1A1 (0.60) CYP2A6CYP2C19CYP3A4CYP2D6CYP2C9
SCHEMBL10146796 0.78 ALDH1A1 (0.58) CYP2A6CYP2C19CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593447-B1 3-PYRIDYL-HETEROARYLCARBOXAMIDE COMPOUNDS AS PESTICIDES BAYER IP GMBH (DE) 2016-08-17 EP disclosed
US-9233951-B2 Heterocyclic compounds as pesticides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-01-12 US disclosed
US-9233951-B2 Heterocyclic compounds as pesticides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-01-12 US disclosed
US-20120094837-A1 Novel Heterocyclic Compounds as Pesticides BAYER CROP SCIENCE AG (DE) 2012-04-19 US disclosed
US-20120094837-A1 Novel Heterocyclic Compounds as Pesticides BAYER CROP SCIENCE AG (DE) 2012-04-19 US disclosed
WO-2012007500-A2 NEW HETEROCYCLIC COMPOUNDS AS PESTICIDES BAYER CROPSCIENCE AG (DE) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120094837-A1 Novel Heterocyclic Compounds as Pesticides DDT, PTMS, ACHE CYP2A6 677/4885CYP2C19 983/4885CYP3A4 155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.